BioLife Solutions Company Insiders

BLFS Stock  USD 23.29  0.93  4.16%   
BioLife Solutions' insiders are aggressively selling. The analysis of insiders' sentiment of trading BioLife Solutions stock suggests that vertually all insiders are panicking at this time. BioLife Solutions employs about 159 people. The company is managed by 11 executives with a total tenure of roughly 48 years, averaging almost 4.0 years of service per executive, having 14.45 employees per reported executive.
Michael Rice  CEO
CEO and President and Director
Aby Mathew  Chairman
Chairman of Scientific Advisory Board, CTO and Sr. VP

Insider Sentiment 0

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2025-04-09Aby J MathewDisposed 569 @ 20.11View
2025-04-01Troy WichtermanDisposed 25687 @ 22.66View
2025-03-17Sarah AebersoldDisposed 2695 @ 25.44View
2025-03-14Sarah AebersoldDisposed 5632 @ 24.96View
2025-03-11Aby J MathewDisposed 1597 @ 25View
2025-03-03Troy WichtermanDisposed 660 @ 25.46View
2025-02-12Aby J MathewDisposed 92 @ 26.54View
Monitoring BioLife Solutions' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.

BioLife Solutions' Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with BioLife Solutions' future performance. Based on our forecasts, it is anticipated that BioLife will maintain a workforce of slightly above 160 employees by June 2025.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

BioLife Solutions Management Team Effectiveness

Return On Tangible Assets is likely to drop to -0.12 in 2025. Return On Capital Employed is likely to drop to -0.02 in 2025. At this time, BioLife Solutions' Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 263.3 M in 2025, whereas Return On Tangible Assets are likely to drop (0.12) in 2025. BioLife Solutions' management efficiency ratios could be used to measure how well BioLife Solutions manages its routine affairs as well as how well it operates its assets and liabilities.
Common Stock Shares Outstanding is likely to gain to about 48.4 M in 2025, despite the fact that Net Loss is likely to grow to (119.5 M).

BioLife Solutions Workforce Comparison

BioLife Solutions is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 101,710. BioLife Solutions adds roughly 159 in number of employees claiming only tiny portion of equities under Health Care industry.

BioLife Solutions Profit Margins

The company has Profit Margin (PM) of (0.12) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.05) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.05.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.410.7021
Way Down
Pretty Stable

BioLife Solutions Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BioLife Solutions insiders, such as employees or executives, is commonly permitted as long as it does not rely on BioLife Solutions' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, BioLife Solutions insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2025-06-01
0.1
1
10
 27,994 
 61,139 
2025-03-01
0.6667
18
27
 459,294 
 38,852 
2024-12-01
0.08
2
25
 20,000 
 164,880 
2024-09-01
0.0455
1
22
 10,000 
 50,537 
2024-06-01
0.0476
1
21
 150,000 
 189,728 
2024-03-01
0.5
18
36
 338,143 
 70,504 
2023-12-01
2.5625
41
16
 1,769,388 
 112,679 
2023-09-01
0.6071
17
28
 76,724 
 50,158 
2023-06-01
0.1633
8
49
 180,000 
 181,605 
2023-03-01
0.678
40
59
 614,079 
 215,711 
2022-09-01
1.45
29
20
 21,041 
 19,449 
2022-06-01
0.8286
29
35
 277,202 
 377,377 
2022-03-01
0.5682
25
44
 490,275 
 277,951 
2021-12-01
0.2639
19
72
 161,036 
 498,596 
2021-09-01
0.3077
20
65
 430,956 
 497,668 
2021-06-01
0.4478
30
67
 284,791 
 482,853 
2021-03-01
0.3836
28
73
 341,409 
 825,538 
2020-12-01
0.2075
11
53
 1,676,211 
 2,984,870 
2020-09-01
0.25
8
32
 1,273,457 
 767,468 
2020-06-01
0.3548
11
31
 6,347,358 
 5,757,080 
2020-03-01
0.7143
40
56
 522,709 
 523,762 
2019-12-01
0.2771
23
83
 162,461 
 772,729 
2019-09-01
0.2738
23
84
 145,093 
 483,473 
2019-06-01
0.4565
21
46
 161,364 
 387,223 
2019-03-01
1.1579
22
19
 267,165 
 146,628 
2018-12-01
0.5
6
12
 62,678 
 123,999 
2018-09-01
0.2917
7
24
 70,620 
 656,005 
2018-06-01
0.3684
7
19
 69,048 
 1,193,526 
2018-03-01
3.5714
25
7
 1,183,048 
 76,984 
2017-06-01
2.6667
8
3
 188,358 
 167,143 
2017-03-01
2.25
9
4
 211,413 
 89,285 
2016-09-01
1.0
3
3
 149,998 
 149,998 
2015-12-01
3.0
3
1
 214,287 
 71,429 
2015-06-01
11.0
11
1
 1,210,881 
 10,000 
2015-03-01
0.5
1
2
 2,143 
 2,143 
2014-03-01
1.0
4
4
 6,642,810 
 3,321,405 
2011-09-01
3.0
3
1
 2,500,000 
 250,000 
2006-06-01
1.2727
14
11
 20,608,558 
 2,010,097 

BioLife Solutions Notable Stakeholders

A BioLife Solutions stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BioLife Solutions often face trade-offs trying to please all of them. BioLife Solutions' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BioLife Solutions' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Michael RiceCEO and President and DirectorProfile
Aby MathewChairman of Scientific Advisory Board, CTO and Sr. VPProfile
Todd BerardVice President of MarketingProfile
Karen FosterVice President - OperationsProfile
Roderick GreefInterim CFO, Interim SecretaryProfile
Sarah JDChief OfficerProfile
Troy WichtermanChief OfficerProfile
Geraint PhillipsSenior OperationsProfile
Troy CPAChief OfficerProfile
Sean WernerChief OfficerProfile
Marcus SchulzChief OfficerProfile

About BioLife Solutions Management Performance

The success or failure of an entity such as BioLife Solutions often depends on how effective the management is. BioLife Solutions management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BioLife management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BioLife management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.11)(0.12)
Return On Capital Employed(0.02)(0.02)
Return On Assets(0.05)(0.05)
Return On Equity(0.06)(0.06)
Please note, the imprecision that can be found in BioLife Solutions' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BioLife Solutions. Check BioLife Solutions' Beneish M Score to see the likelihood of BioLife Solutions' management manipulating its earnings.

BioLife Solutions Workforce Analysis

Traditionally, organizations such as BioLife Solutions use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BioLife Solutions within its industry.

BioLife Solutions Manpower Efficiency

Return on BioLife Solutions Manpower

Revenue Per Employee517.3K
Revenue Per Executive7.5M
Net Loss Per Employee126.9K
Net Loss Per Executive1.8M
Working Capital Per Employee729.7K
Working Capital Per Executive10.5M

Additional Tools for BioLife Stock Analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.